Association of gghrelin polymorphisms with metabolic syndrome in Han Nationality Chinese

Biomedical and Environmental Sciences

Volumn 21, Issue 3, 2008, Pages 188-192

  Xu, Ling Ling ^a   Xiang, Hong Ding ^a   Qiu, Chang Chun ^b   Xu, Qun ^b  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^b INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

Author keywords

Ghrelin; Metabolic syndrome; Polymorphism; The Han Nationality

Indexed keywords

GHRELIN;

ARTICLE; ASIAN; CHINA; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HUMAN; MALE; METABOLIC SYNDROME X; MIDDLE AGED;

ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GHRELIN; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; POLYMORPHISM, GENETIC;

EID: 47949096784     PISSN: 08953988     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-3988(08)60027-6     Document Type: Article

References (25)

1. Kojima M, Hosoda H, Date Y, et al. (1999). Ghrelin is a growth - hormone - releasing acylated peptide from stomach. Nature 402, 656-660.
2. Broglio F, Arvat E, Benso A, et al. (2002). Ghrelin, a natural GH secretagogue produced by the stomach, induces hyperglycemia and reduces insulin secretion in humans. J Clin Endocrinol Metab 86, 5083-5086.
3. Wren A M, Small C J, Ward H L, et al. (2000). The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion. Endocrinology 141, 4325-4328.
4. Nakazato M, Murakami N, Date Y, et al. (2001). A role for ghrelin in the central regulation of feeding. Nature 409, 194-198.
5. Muccioli G, Tshop M, Papotti M, et al. (2002). Neuroendocrine and peripheral activities of ghrelin: implications in metabolism and obesity. Eur J Pharmacol 440, 235-254.
6. Mclaughlin T, Abbasi F, Lamendola C, et al. (2004). Plasma ghrelin concentrations are decreased in insulin-resistant obese adults relative to equally obese insulin-sensitive controls. J Clin Endocrinol Metab 89, 1630-1635.
7. Katsuki A, Urakawa H, Gabazza E C, et al. (2004). Circulating levels of active ghrelin is associated with abdominal adiposity, hyperinsulinemia and insulin resistance in patients with type 2 diabetes mellitus. Eur J Endocrinol 151, 573-577.
8. 2+ signaling in β-cells. Diabetes 53, 3142-3151.
9. Wierup N, Yang S, McEvilly R J, et al. (2004). Ghrelin is expressed in a novel endocrine cell type in developing rat islets and inhibits insulin secretion from INS-1(832/13) cells. J Histochem Cytochem 52, 301-310.
10. Langenberg C, Bergstrom J, Laughlin G A, et al. (2005). Ghrelin and the Metabolic syndrome in older Adults. J Clin Endocrinol Metab 90, 6448-6453.
11. Wajanrajch M P, Ten I S, Gertner J M, et al. (2000). Genomic organization of human ghrelin gene. J Endocr Genet 1, 231-233.
12. Poykko S, Ukkola O, Kauma H, et al. (2003). Ghrelin Arg51Gln mutation is a risk factor for type 2 diabetes and hypertension in a random sample of middle-aged subjects. Diabetologia 46, 455-458.
13. Poykko S M, Kellokoski E, Horkko S, et al. (2003). Low plasma ghrelin is associated with insulin resistance, hypertension, and the prevalence of type 2 diabetes. Diabetes 52, 2546-2553.
14. Ukkola O, Ravussin E, Jacobson P, et al. (2002). Role of ghrelin polymorphisms in obesity based on three different studies. Obes Res 10, 782-791.
15. Bing C, Ambye L, Fenger M, et al. (2005). Large-scale studies of the Leu72Met polymorphism of the ghrelin gene in relation to the metabolic syndrome and associated quantitative traits. Diabet Med 22, 1157-1160.
16. International Diabetes Federation (2005). The IDF consensus worldwide definition of the metabolic syndrome. Available from http: //www. idf.org/webdata/docs/Metabolic_syndrome_definition. Pdf. Accessed 2 September.
17. Kim S Y, Jo D S, Hwang P H, et al. (2006). Preproghrelin Leu72Met polymorphism is not associated with type 2 diabetes mellitus. Metabolism Clin & Exp 55, 366-370.
18. Dunstan D W, Zimmet P Z, Welborn T A, et al. (2002). The rising prevalence of diabetes and impaired glucose tolerance. The Australian Diabetes, Obesity and Lifestyle Study. Diabetes Care 25, 829-834.
19. Ford E S, Giles W H, Dietz W H (2002). Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 287, 356-359.
20. Gu D F, Reynolds K, Yang W J, et al. (2005). The prevalence of metabolic syndrome in the general adult population aged 35-74 years in China. Chin J Diabetes 13, 181-186.
21. Ott V, Fasshauer M, Dalski A, et al. (2002). Direct peripheral effects of ghrelin include suppression of adiponectin expression. Horm Metab Res 34, 640-645.
22. Dixit V D, Schaffer E M, Pyle R S, et al. (2004). Ghrelin inhibits leptin- and activation-induced proinflammatory cytokine expression by human monocytes and T cells. J Clin Invest 114, 57-66.
23. Misquitta C M, Iyer V R, Werdyiuk E S, et al. (2001). The role of 3′-untranslated region (3′-UTR) mediated mRNA stability in cardiovascular pathophysiology. Mol Cell Biochem 224, 53-67.
24. Tanaka M, Hayashida Y, Nakao N, et al. (2001). Testis-specific and developmentally induced expression of a ghrelin gene-derived transcript that encodes a novel polypeptide in the mouse. Biochim Biophys Acta 1522, 62-65.
25. Steinle N I, Pollin T I, O'Connell J R, et al. (2005). Variants in the ghrelin gene are associated with metabolic syndrome in the Old Order Amish. J Clin Endocrinol Metab 90, 6672-6677.